Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price
on Feb 4, 2025
Avid Bioservices Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Avid Bioservices stock had an average target of 12.25, with a low estimate of 12 and a high estimate of 12.5.
Analyst Consensus: Hold
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
The average analyst rating for Avid Bioservices stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $13 | Buy → Hold | Downgrades | $12 → $13 | +0.08% | Nov 7, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $12 | Buy | Maintains | $8 → $12 | -3.92% | Sep 10, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | -3.92% | Sep 10, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 10, 2024 |
Financial Forecast
Revenue This Year
166.37M
from 139.91M
Increased by 18.91%
Revenue Next Year
194.26M
from 166.37M
Increased by 16.76%
EPS This Year
-0.34
from -2.23
EPS Next Year
-0.06
from -0.34
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 172.3M | 206.0M | 253.1M | ||
| Avg | 166.4M | 194.3M | 234.9M | ||
| Low | 159.0M | 180.9M | 212.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.1% | 23.8% | 30.3% | ||
| Avg | 18.9% | 16.8% | 20.9% | ||
| Low | 13.6% | 8.7% | 9.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | 0.12 | 0.19 |
| Avg | -0.34 | -0.06 | 0.18 |
| Low | -0.40 | -0.21 | 0.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.